Drugs / ASP3700
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02285465 | Nov 2014 | — | Astellas Pharma Europe B.V. | Withdrawn | No outcome recorded Stop: Business |
| Phase 1 | NCT02155504 | May → Oct 2014 | — | Astellas Pharma Europe B.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP3700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02155504 ↗ |
| Route | Oral | “Oral” NCT02285465 ↗ |